Very few competitive athletes in this large registry study had evidence of cardiac involvement.
Much remains unknown about how SARS-CoV-2 infection affects the hearts of competitive athletes. Investigators conducted a prospective, multicenter, observational registry study that included people from 42 colleges and universities.
Among the 19,378 athletes enrolled in the registry, 3384 (18%) tested positive for COVID-19. Of the 3018 who qualified for the analysis, 33% were asymptomatic, and 29% had mild symptoms, typically loss of taste or smell (40%), headache (39%), and sore throat (31%). Another 13% had cardiopulmonary symptoms (chest pain, exercise intolerance, palpitations, shortness of breath). Abnormalities were found on electrocardiography (ECG) in 21 of 2999 people, on transthoracic echocardiography in 24 of 2556, and on cardiac …
Reviewing Author
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association
DisclosuresConsultant/Advisory BoardUnited Healthcare; Element Science; Eyedentifeye, F-Prime
EquityHugo Health; Refactor Health; Element Science
Grant/Research SupportPfizer; Agency for Healthcare Research and Quality; Janssen Research and Development, National Institute of Biomedical Imaging and Engineering; National Heart, Lung, and Blood Institute; Centers for Disease Control and Prevention; National Cancer Institute; American Heart Association